Christopher R. Stone

Array ( [id] => 4539949 [patent_doc_number] => 07875602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Camptothecin derivatives as chemoradiosensitizing agents' [patent_app_type] => utility [patent_app_number] => 11/444150 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30616 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875602.pdf [firstpage_image] =>[orig_patent_app_number] => 11444150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518924 [patent_doc_number] => 07973025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Compositions and methods of treating retinal disease' [patent_app_type] => utility [patent_app_number] => 11/441848 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 19501 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973025.pdf [firstpage_image] =>[orig_patent_app_number] => 11441848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873804 [patent_doc_number] => 20080200538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Inhibition of Monocyte Survival, Differentiation, or Proliferation' [patent_app_type] => utility [patent_app_number] => 11/915554 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10590 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200538.pdf [firstpage_image] =>[orig_patent_app_number] => 11915554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687418 [patent_doc_number] => 20090176873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'NOVEL USE OF ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/920346 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5052 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176873.pdf [firstpage_image] =>[orig_patent_app_number] => 11920346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10148911 [patent_doc_number] => 09181184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives' [patent_app_type] => utility [patent_app_number] => 11/440473 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23235 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11440473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5604299 [patent_doc_number] => 20060265815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Antimicrobial matrix' [patent_app_type] => utility [patent_app_number] => 11/432911 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2997 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20060265815.pdf [firstpage_image] =>[orig_patent_app_number] => 11432911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609172 [patent_doc_number] => 20060270688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Compounds for modulating TRPV3 function' [patent_app_type] => utility [patent_app_number] => 11/431942 [patent_app_country] => US [patent_app_date] => 2006-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 52117 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270688.pdf [firstpage_image] =>[orig_patent_app_number] => 11431942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625879 [patent_doc_number] => 20060264384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Compositions and methods for treatment for neoplasms' [patent_app_type] => utility [patent_app_number] => 11/429544 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 119 [patent_no_of_words] => 14279 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264384.pdf [firstpage_image] =>[orig_patent_app_number] => 11429544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5224779 [patent_doc_number] => 20070254045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Method for treating head and neck cancer' [patent_app_type] => utility [patent_app_number] => 11/412792 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5316 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254045.pdf [firstpage_image] =>[orig_patent_app_number] => 11412792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183578 [patent_doc_number] => 20070054932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Inhibitors of ABC drug transporters at the blood-brain barrier' [patent_app_type] => utility [patent_app_number] => 11/411423 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 15787 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054932.pdf [firstpage_image] =>[orig_patent_app_number] => 11411423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733595 [patent_doc_number] => 20060258712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods for modulating bladder function' [patent_app_type] => utility [patent_app_number] => 11/408323 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15276 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258712.pdf [firstpage_image] =>[orig_patent_app_number] => 11408323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733627 [patent_doc_number] => 20060258744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Medicament for preventing and/or treating peripheral neuropathies' [patent_app_type] => utility [patent_app_number] => 11/407351 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7425 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258744.pdf [firstpage_image] =>[orig_patent_app_number] => 11407351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305920 [patent_doc_number] => 08227455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Methods of treating cell proliferative disorders' [patent_app_type] => utility [patent_app_number] => 11/407233 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 29 [patent_no_of_words] => 38662 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11407233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733580 [patent_doc_number] => 20060258697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Method of augmenting the antitumor activity of anticancer agents' [patent_app_type] => utility [patent_app_number] => 11/405377 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8022 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258697.pdf [firstpage_image] =>[orig_patent_app_number] => 11405377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924608 [patent_doc_number] => 20060241164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Pharmacological treatment for sleep apnea' [patent_app_type] => utility [patent_app_number] => 11/404280 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10783 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241164.pdf [firstpage_image] =>[orig_patent_app_number] => 11404280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247876 [patent_doc_number] => 20070244110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Treatment of prostate cancer, melanoma or hepatic cancer' [patent_app_type] => utility [patent_app_number] => 11/404078 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5588 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244110.pdf [firstpage_image] =>[orig_patent_app_number] => 11404078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678442 [patent_doc_number] => 20060183798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent' [patent_app_type] => utility [patent_app_number] => 11/402961 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19645 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183798.pdf [firstpage_image] =>[orig_patent_app_number] => 11402961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995143 [patent_doc_number] => 20070010488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Compounds for modulating cell proliferation' [patent_app_type] => utility [patent_app_number] => 11/404511 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12665 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010488.pdf [firstpage_image] =>[orig_patent_app_number] => 11404511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834269 [patent_doc_number] => 20060246099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Compositions containing piperazine compounds' [patent_app_type] => utility [patent_app_number] => 11/401914 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7498 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246099.pdf [firstpage_image] =>[orig_patent_app_number] => 11401914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851855 [patent_doc_number] => 20060235046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Use of an epidermal growth factor receptor kinase inhibitor (EGFR) in gefitinib resistant patients' [patent_app_type] => utility [patent_app_number] => 11/403170 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3894 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235046.pdf [firstpage_image] =>[orig_patent_app_number] => 11403170 [rel_patent_id] =>[rel_patent_doc_number] =>)